Loading clinical trials...
Loading clinical trials...
Randomized Open-label Controlled Trial Evaluating a Single-dose Intravenous Dalbavancin Versus Standard Antibiotic Therapy During Catheter-related Bloodstream Infections Due to Staphylococcus Aureus
Conditions
Interventions
Dalbavancin administration
Standard antibiotic therapy
Locations
2
France
Infectious Diseases Department, Raymond-Poincaré Hospital - APHP
Garches, France
Infectious Diseases Department, CH PERIGUEUX
Périgueux, France
Start Date
June 23, 2023
Primary Completion Date
September 23, 2025
Completion Date
September 23, 2026
Last Updated
April 6, 2025
NCT05899140
NCT06319235
NCT01879761
NCT06456424
NCT04210505
NCT07280598
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions